Stock ASPENBIO PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. AspenBio Pharma, Inc. Nasdaq

Equities

US0453462022

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for AspenBio Pharma, Inc.
Apr. 29 Top Cryptocurrencies Fall; Bitcoin Drops Below $63,000 MT
Apr. 29 Wall St edges up as Tesla and Apple gain; Fed decision awaited RE

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JPMorgan Adjusts Price Target on Riot Platforms to $15.50 From $15, Maintains Overweight Rating
MT
B. Riley Cuts Price Target on Riot Platforms to $16 From $17, Maintains Buy Rating
MT
ATB Capital Starts Riot Platforms With Outperform Rating, $20 Price Target
MT
JPMorgan Upgrades Riot Platforms to Overweight From Neutral, Price Target is $15
MT
B. Riley Securities Adjusts Riot Platforms' Price Target to $17 From $14, Maintains Buy Rating
MT
Cantor Fitzgerald Raises Riot Platforms' Price Target to $20 From $19, Keeps Overweight Rating
MT
Wall St set to rise after selloff as traders reassess rate bets
RE
Futures climb after Wall St sell-off; rate-cut jitters loom
RE
Needham Adjusts Riot Platforms Price Target to $18 From $19, Maintains Buy Rating
MT
B. Riley Adjusts Riot Platforms' Price Target to $14 From $17, Keeps Buy Rating
MT
Wall Street little changed after inflation data
RE
Wall Street dips as inflation, labor market data dent rate cut hopes
RE
Wall Street drops as inflation data dulls rate-cut hopes
RE
Wall St eyes flat open as inflation data dampens rate-cut hopes
RE
Wall Street rises as rate-cut bets strengthen
RE
Wall St set to open higher as investors pin hopes on Fed rate cuts
RE
JPMorgan Upgrades Riot Platforms to Neutral From Underweight, Raises Price Target to $12 From $8
MT
Roth MKM Raises Price Target on Riot Platforms to $22.50 From $19.50, Maintains Buy Rating
MT
HC Wainwright Raises Price Target on Riot Platforms to $20 From $18, Keeps Buy Rating
MT
Wall Street ends down as megacaps give back gains
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RIOT Stock
  4. Stock
  5. News AspenBio Pharma, Inc.
  6. Analyst Reco.